![]() |
市场调查报告书
商品编码
1986772
宠物糖尿病照护市场报告:按解决方案、动物种类、分销管道和地区划分(2026-2034 年)Pet Diabetes Care Market Report by Solution (Treatment, Glucose Monitoring Devices), Animal Type (Dogs, Cats), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Online Stores), and Region 2026-2034 |
||||||
2025年,全球宠物糖尿病照护市场规模达23亿美元。展望未来,IMARC集团预测,到2034年,该市场规模将达到40亿美元,2026年至2034年的复合年增长率为6.17%。推动这一增长的关键因素包括宠物肥胖症的日益普遍、宠物「人性化」的兴起、主要企业广泛的研发活动以及消费者购买力的提高。
兽医糖尿病照护是指兽医学中专门诊断、治疗和管理犬猫糖尿病的领域。它涵盖了对患有糖尿病的宠物的全面护理和支持。糖尿病是一种慢性疾病,其特征是身体无法正常调节血糖值。兽医糖尿病照护包括定期血糖监测、胰岛素注射、饮食管理和生活方式调整等多个面向。接受过该领域培训的兽医和兽医专业人员与饲主密切合作,制定个人化的治疗方案,提供疾病相关知识,并提供持续的支援。兽医糖尿病照护的目标是透过结合医疗干预、饮食管理和生活方式改善,优化宠物的生命质量,预防糖尿病相关的健康併发症,并有效控制血糖。
久坐的生活方式、肥胖、遗传倾向以及宠物因老化而导致的糖尿病盛行率上升,将在预测期内推动市场成长。此外,宠物「人性化」趋势的兴起以及饲主日益增长的为爱宠提供最佳医疗保健的愿望,正在加速饲主对相关产品的接受度。饲主愿意在定期兽医检查、糖尿病管理工具和专业营养疗法方面投入更多,以确保宠物获得适当且及时的护理。此外,兽医学和技术的许多进步,包括宠物糖尿病治疗方案的扩展(例如改良的胰岛素配方、血糖值监测设备以及可实现远端监测和咨询的远距远端照护解决方案),也在促进市场成长。同时,饲主和兽医专业人员对宠物糖尿病的认识和知识的普及也有助于市场成长。
宠物肥胖率上升
宠物肥胖症的日益普遍是推动宠物糖尿病照护解决方案需求成长的主要因素。随着越来越多的宠物超重或肥胖,它们患糖尿病的风险也随之增加。宠物饲主越来越意识到宠物肥胖带来的健康风险,包括糖尿病风险的增加,因此他们正在寻求解决和预防这些问题的方案。由此,市场对体重管理计划、特製食品和运动计划的需求日益增长,这些计划旨在帮助宠物保持健康体重,并降低糖尿病及相关疾病的风险。此外,人们对宠物肥胖症日益增长的关注也推动了新型宠物糖尿病护理产品和服务的发展,这些产品和服务旨在透过有效的体重管理策略帮助饲主预防和控制宠物糖尿病。
人们对宠物健康和保健的兴趣日益浓厚
人们对宠物健康和福祉日益关注,这是推动市场发展的另一个主要因素。饲主在确保宠物整体健康方面投入巨资,并寻求预防性医疗保健方案以及对糖尿病等慢性疾病的全面管理。他们更积极主动监测宠物的健康状况,定期带宠物进行兽医检查,并更加关注潜在的健康问题。宠物饲主健康意识的显着转变,导致对宠物糖尿病专业照护的需求增加,包括定期血糖值监测、胰岛素注射和饮食管理。市场正透过创新产品和服务来应对这一趋势,例如先进的血糖监测系统、胰岛素笔和糖尿病宠物食品。宠物饲主也积极寻求有关宠物糖尿病管理的资讯和资源,从而迅速提高人们对此主题的认识和了解。
兽医学和技术的进步
兽医学和技术的持续进步显着改善了宠物糖尿病的管理,为市场带来了积极的变革。这些进步包括开发出更精准、更容易使用的血糖值监测系统,使饲主能够方便、准确地监测宠物的血糖值。此外,远端医疗和远端监测工具的引入,使得糖尿病管理更加便捷高效,饲主无需频繁前往宠物医院即可获得兽医的指导和支持。同时,电子健康记录和数据分析的广泛应用也提升了糖尿病宠物的整体管理和治疗效果。这些兽医学和技术的创新为宠物饲主提供了更好的工具和资源来管理宠物的疾病,从而改善了糖尿病宠物的整体护理和生活品质。
The global pet diabetes care market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The increasing prevalence of obesity in pets, the emerging pet humanization trend, extensive research and development (R&D) activities by key players, and rising expenditure capacities of consumers are some of the major factors propelling the market.
Pet diabetes care refers to the specialized field of veterinary medicine that deals with the diagnosis, treatment, and management of diabetes in dogs and cats. It involves comprehensive care and support for pets with diabetes mellitus, a chronic condition characterized by the body's inability to properly regulate blood sugar levels. Pet diabetes care encompasses various aspects, including the regular monitoring of blood glucose levels, insulin administration, dietary management, and lifestyle modifications of pets. Veterinarians and veterinary professionals trained in this field work closely with pet owners to create individualized treatment plans, educate them about the disease, and provide ongoing support. The goal of pet diabetes care is to optimize the pet's quality of life, prevent health complications associated with diabetes, and achieve efficient glycemic control through a combination of medical intervention, dietary management, and lifestyle modifications.
The rising prevalence of diabetes in pets due to sedentary lifestyles, obesity, genetic predisposition, and an aging pet population will stimulate the growth of the market during the forecast period. Moreover, the emerging trend of pet humanization and the growing desire of pet owners to provide optimal healthcare for companion animals have accelerated the product adoption rate among pet owners. Pet owners are willing to invest more in regular veterinary visits, diabetes management tools, and specialized diets to ensure that their pets receive proper and timely care. Apart from this, numerous advancements in veterinary medicine and technology, including the expansion of the range of treatment options available for pet diabetes such as improved insulin formulations, glucose monitoring devices, and telemedicine solutions that facilitate remote monitoring and consultation is propelling the market growth. Furthermore, the heightening awareness and education about pet diabetes among owners and veterinary professionals is contributing to the market growth.
Increase in pet obesity rates
The rising prevalence of obesity among pets is a major factor driving the demand for pet diabetes care solutions. As more and more pets become overweight or obese, they are at a higher risk of developing diabetes. Pet owners are becoming increasingly aware of the health risks associated with obesity in their pets, including the higher likelihood of diabetes, and are therefore seeking solutions to address and prevent these conditions. This in turn has led to a growing demand for weight management programs, specialized diets, and exercise regimens designed to help pets maintain a healthy weight and reduce the risk of developing diabetes and associated conditions. Besides this, the increasing focus on combating pet obesity is encouraging the development of new products and services related to pet diabetes care, aimed at helping pet owners prevent and manage diabetes through effective weight management strategies.
Growing focus on pet health and wellness
The growing focus on pet health and wellness is another major driver in the market. Pet owners are heavily investing in ensuring the overall well-being of their pets and are seeking preventive healthcare solutions and comprehensive management of chronic conditions like diabetes. They have become more proactive in monitoring their pets' health, are going for regular veterinary check-ups and being more vigilant about potential health issues. This substantial shift in pet owners' mindset has strengthened the demand for specialized pet diabetes care, including regular monitoring of blood glucose levels, insulin administration, and dietary management. The market is responding to this trend by offering innovative products and services such as advanced glucose monitoring systems, insulin pens, and specialized diabetic pet food formulations. Pet owners are also actively seeking information and resources on managing diabetes in pets, leading to a surge in awareness and education on the topic.
Advancements in veterinary medicine and technology
Constant advancements in veterinary medicine and technology have significantly improved the management of diabetes in pets and are driving positive changes in the market. These advancements include the development of more accurate and user-friendly glucose monitoring systems, which enable pet owners to monitor their pets' blood sugar levels conveniently and accurately. Additionally, the integration of telemedicine and remote monitoring tools has enabled more convenient and efficient diabetes management, as pet owners can receive guidance and support from veterinary professionals without the need for frequent in-person visits. Furthermore, the increasing use of electronic health records and data analytics has improved the overall management and treatment outcomes of pets with diabetes. These innovations in veterinary medicine and technology are providing pet owners with better tools and resources for managing the disease in their pets, enhancing the overall care and quality of life for diabetic pets.
Treatment represents the most popular solution
Treatment plays a crucial role in driving the market growth as it encompasses a range of interventions and therapies aimed at managing diabetes in pets. Effective treatment options are essential to provide optimal care and improve the quality of life for pets with diabetes. Treatment fuels the market growth by creating a consistent and steady demand for various products and services, such as insulin formulations, glucose monitoring systems, specialized diabetic pet food, and veterinary consultations.
Furthermore, the easy availability of diverse treatment options allows pet owners and veterinary professionals to tailor the management approach to the individual needs of each pet, which in turn is propelling the market growth. Moreover, ongoing advancements in treatment options, including improved insulin formulations and delivery methods, advanced glucose monitoring technologies, and personalized nutrition, further contribute to the growth of the market.
Dogs dominate the market
Dogs play a significant role in propelling the market due to their high prevalence of diabetes and the growing awareness of this condition among dog owners. Dogs are more susceptible to developing diabetes compared to other pets, and as a result, there is a greater demand for specialized care and management options for diabetic dogs. The increasing prevalence of obesity in dogs, which is a major risk factor for diabetes, further contributes to the need for pet diabetes care solutions for dogs.
Furthermore, dog owners are becoming more educated about the symptoms, diagnosis, and treatment of diabetes in dogs, leading to more frequent veterinary visits and the adoption of appropriate disease management strategies. This growing awareness drives the development and availability of specific products and services tailored to diabetic dogs, including glucose monitoring devices, insulin formulations, diabetic dog food, and educational resources. The unique role of dogs in the market for pet diabetes care underscores the importance of addressing their specific needs and fueling advancements in diabetes management for this companion animal.
Veterinary hospitals and clinics hold the largest share in the market
Veterinary hospitals and clinics are the primary providers of specialized care and treatment for pets with diabetes. These healthcare facilities serve as the central hub for diagnosing, monitoring, and managing diabetes in pets. Veterinary hospitals and clinics offer crucial services such as blood glucose monitoring, insulin administration, dietary counseling, and regular check-ups to ensure effective diabetes management in pets. They play a vital role in educating pet owners about the importance of diabetes care, including the need for regular veterinary visits, adherence to treatment plans, and lifestyle modifications. Furthermore, these healthcare facilities often stock and dispense diabetes-related products such as insulin, glucose monitoring devices, and specialized diabetic pet food, contributing to the widespread availability and accessibility of these essential supplies. Veterinary hospitals and clinics are at the forefront of research and advancements in pet diabetes care, driving innovations and improving treatment options. Their expertise and guidance are crucial in improving the quality of life of pets with diabetes and fostering the growth of the market.
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for pet diabetes care.
North America held the biggest share in the market since the region has a high pet ownership rate and a strong culture of pet care, resulting in a large market for pet healthcare products and services, including diabetes care. The rising awareness and understanding of pet diabetes among pet owners in North America contributes to the high demand for specialized care and treatment options. Veterinary clinics and hospitals in the North America region are at the forefront of research, innovation, and advancements in pet diabetes management, fostering the development of new products and treatment protocols.
Additionally, North America has a well-established veterinary healthcare infrastructure with an extensive network of veterinary professionals and specialized pet care facilities, ensuring easy accessibility to pet diabetes care. The large presence of leading pharmaceutical and healthcare companies in the region further supports the growth of the market in North America through the development and distribution of diabetes management products, including insulin, glucose monitoring devices, and specialized pet food.
The market is experiencing a lower-than-anticipated demand compared to pre-pandemic levels. However, this is likely to witness a paradigm shift over the next decade with the development of advanced glucose monitoring systems specifically designed for pets. Moreover, there have been advancements in insulin formulations and delivery methods, offering improved options for insulin administration and absorption. Key players are also introducing long-acting insulin formulations that provide more stable blood glucose control and reduce the frequency of injections. Additionally, the leading manufacturers are integrating telemedicine and remote monitoring technologies, enabling pet owners to consult with veterinary professionals and receive guidance on diabetes management from the comfort of their homes. We also expect the market to witness new entrants, consolidation of product portfolios, increased research-related efforts by key players, and a rise in strategic collaborations to drive healthy competition within the domain.